Do you want to read an article? Please log in or register.
Opening of ATP-sensitive potassium channels causes migraine attacks: a new target for the treatment of migraine
Migraine and Headache
Related content
RECOMMENDED
Migraine and Headache
Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Cephalalgia.
Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Houle TT, Hoek TCVD, Martinelli D, Terwindt GM, International Headache Society Clinical Trials Committee
doi: 10.1177/0333102420941839.
Migraine and Headache
Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ)
Headache.
Hareendran A, Skalicky A, Mannix S, Lavoie S, Desai P, Bayliss M, Thach AV, Mikol DD, Buse DC
doi: 10.1111/head.13420.
Migraine and Headache
An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of MWA or MWoA in Pediatric Participants
Headache.
McVige JW, Hogan RM, Shanahan CM, Amend DL, Ferger SM
doi: 10.1111/head.13922.
Migraine and Headache
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients
Headache
Smith TR, Winner P, Aurora SK, Jeleva M, Hocevar-Trnka J, Shrewsbury SB
doi: 10.1111/head.14184
RECOMMENDED
Migraine and Headache
Emerging Treatment Targets for Migraine and Other Headaches
Headache.
Bertels Z, Pradhan AAA
doi: 10.1111/head.13585.
RECOMMENDED
Migraine and Headache
The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
Headache.
American Headache Society
doi: 10.1111/head.13456.
RECOMMENDED
Migraine and Headache
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
Cephalalgia.
Brandes JL, Klise S, Krege JH, Case M, Khanna R, Vasudeva R, Raskin J, Pearlman EM, Kudrow D
doi: 10.1177/0333102419864132.
RECOMMENDED
Migraine and Headache
Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
Cephalalgia.
Diener HC, Tassorelli C, Dodick DW, Silberstein SD, Lipton RB, Ashina M, Becker WJ, Ferrari MD, Goadsby PJ, Pozo-Rosich P, Wang SJ, Mandrekar J, International Headache Society Clinical Trials Standing Committee
doi: 10.1177/0333102419828967.
RECOMMENDED
Migraine and Headache
A Real-World Analysis of Patient Characteristics, Treatment Patterns, and Level of Impairment in Patients With Migraine Who are Insufficient Responders vs Responders to Acute Treatment
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Lombard L, Ye W, Nichols R, Jackson J, Cotton S, Joshi S
doi: 10.1111/head.13835.